412 related articles for article (PubMed ID: 11046073)
21. Selective estrogen receptor modulators. An aid in unraveling the links between estrogen and breast cancer.
Fuqua SA; Russo J; Shackney SE; Stearns ME
Postgrad Med; 2001 Mar; Spec No():3-10. PubMed ID: 11296736
[TBL] [Abstract][Full Text] [Related]
22. The molecular determinants of estrogen receptor pharmacology.
McDonnell DP
Maturitas; 2004 Aug; 48 Suppl 1():S7-12. PubMed ID: 15337242
[TBL] [Abstract][Full Text] [Related]
23. [Estrogen receptor subtypes and the regulatory effect of receptor ligand binding on gene transcription].
An SJ; Zhang YX
Sheng Li Ke Xue Jin Zhan; 2002 Oct; 33(4):309-12. PubMed ID: 12650065
[TBL] [Abstract][Full Text] [Related]
24. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
Ho SM
J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
[TBL] [Abstract][Full Text] [Related]
25. Evolution of the tissue selective estrogen complex (TSEC).
Komm BS; Mirkin S
J Cell Physiol; 2013 Jul; 228(7):1423-7. PubMed ID: 23359290
[TBL] [Abstract][Full Text] [Related]
26. Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA.
Labrie F
Endocr Relat Cancer; 2006 Jun; 13(2):335-55. PubMed ID: 16728567
[TBL] [Abstract][Full Text] [Related]
27. [Selective estrogen receptor modulators (SERMs) in the practice].
Nagykálnai T
Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896
[TBL] [Abstract][Full Text] [Related]
28. Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting.
Hall JM; McDonnell DP
Mol Interv; 2005 Dec; 5(6):343-57. PubMed ID: 16394250
[TBL] [Abstract][Full Text] [Related]
29. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
30. Selective estrogen modulators as an anticancer tool: mechanisms of efficiency and resistance.
Sengupta S; Jordan VC
Adv Exp Med Biol; 2008; 630():206-19. PubMed ID: 18637493
[TBL] [Abstract][Full Text] [Related]
31. The cardiovascular effects of selective estrogen receptor modulators.
Christodoulakos GE; Lambrinoudaki IV; Botsis DC
Ann N Y Acad Sci; 2006 Dec; 1092():374-84. PubMed ID: 17308162
[TBL] [Abstract][Full Text] [Related]
32. Coregulator function: a key to understanding tissue specificity of selective receptor modulators.
Smith CL; O'Malley BW
Endocr Rev; 2004 Feb; 25(1):45-71. PubMed ID: 14769827
[TBL] [Abstract][Full Text] [Related]
33. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol.
Nelson ER
Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155
[TBL] [Abstract][Full Text] [Related]
34. Molecular perspectives on selective estrogen receptor modulators (SERMs): progress in understanding their tissue-specific agonist and antagonist actions.
Lonard DM; Smith CL
Steroids; 2002 Jan; 67(1):15-24. PubMed ID: 11728517
[TBL] [Abstract][Full Text] [Related]
35. [Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator].
Imai Y; Kato S
Clin Calcium; 2010 Mar; 20(3):339-44. PubMed ID: 20190363
[TBL] [Abstract][Full Text] [Related]
36. Development of an ER action indicator mouse for the study of estrogens, selective ER modulators (SERMs), and Xenobiotics.
Nagel SC; Hagelbarger JL; McDonnell DP
Endocrinology; 2001 Nov; 142(11):4721-8. PubMed ID: 11606437
[TBL] [Abstract][Full Text] [Related]
37. From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).
Wardell SE; Nelson ER; McDonnell DP
Steroids; 2014 Nov; 90():30-8. PubMed ID: 25084324
[TBL] [Abstract][Full Text] [Related]
38. Agonist-like SERM effects on ERalpha-mediated repression of MMP1 promoter activity predict in vivo effects on bone and uterus.
Scafonas A; Reszka AA; Kimmel DB; Hou XS; Su Q; Birzin ET; Kim S; Chen HY; Tan Q; Roher SP; Dininno F; Hammond ML; Rodan GA; Towler DA; Schmidt A
J Steroid Biochem Mol Biol; 2008 Jun; 110(3-5):197-206. PubMed ID: 18508261
[TBL] [Abstract][Full Text] [Related]
39. An overview of current and emerging SERMs.
Komm BS; Mirkin S
J Steroid Biochem Mol Biol; 2014 Sep; 143():207-22. PubMed ID: 24667357
[TBL] [Abstract][Full Text] [Related]
40. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator.
DuSell CD; Umetani M; Shaul PW; Mangelsdorf DJ; McDonnell DP
Mol Endocrinol; 2008 Jan; 22(1):65-77. PubMed ID: 17872378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
